Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study.
Phillip J MeaseRobert B M LandeweProton RahmanHasan TahirAtul SinghalElke BoettcherSandra NavarraAimee ReadieShephard MpofuEumorphia Maria DelichaLuminita PricopDésirée Mfm van der HeijdePublished in: RMD open (2021)
NCT02404350.